Valuation: BioNexus Gene Lab Corp.

Market Cap 3.72M 3.23M 3.02M 2.77M 5.22M 355M 5.29M 35.39M 13.89M 177M 13.98M 13.67M 590M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value -91.52K -79.42K -74.37K -68.03K -128K -8.72M -130K -870K -341K -4.36M -344K -336K -14.5M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
64.41%
Yield 2024 *
-
Yield 2025 -
1 day+1.95%
1 week+18.94%
Current month+18.94%
1 month-25.24%
3 months-21.54%
6 months-25.59%
Current year-60.25%
1 week 1.22
Extreme 1.22
1.58
1 month 1.22
Extreme 1.22
2
Current year 1.07
Extreme 1.07
4.14
1 year 1.07
Extreme 1.07
6.1
3 years 1.07
Extreme 1.07
33.9
5 years 1.07
Extreme 1.07
270
10 years 1.07
Extreme 1.07
414
Manager TitleAgeSince
Chief Executive Officer 43 11/12/2023
Director of Finance/CFO 63 17/06/2025
Director TitleAgeSince
Director/Board Member 71 07/03/2022
Director/Board Member 43 11/12/2023
Director/Board Member 51 11/12/2023
Date Insider Type Main position Quantity % Market Cap.
19/07/23 Other

Chief Financial Officer

4,797,709 -
19/07/23 Other

Chief Operating Officer

12,500,460 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.95%+18.94%-72.26%-90.31% 3.72M
+0.93%-1.43%+1.61%+14.93% 48.57B
+0.24%+3.23%+440.96%+569.26% 41.95B
-1.58%-2.69%+30.37%+5.51% 38.85B
+0.78%+2.21%+10.28%+75.56% 37.24B
+2.47%+8.33%+15.16%+48.37% 30.67B
-0.46%+1.39%+36.25%+125.19% 16.41B
+1.87%-0.89% - - 16.1B
+0.29%+1.81%+4.92%+18.60% 13.97B
-1.33%-2.65%+3.68%-35.95% 12.62B
Average +0.48%+1.05%+52.33%+81.24% 25.64B
Weighted average by Cap. +0.37%+0.39%+88.70%+128.92%

Financials

2024 2025
Net sales 9.51M 8.25M 7.73M 7.07M 13.35M 906M 13.52M 90.41M 35.48M 453M 35.71M 34.93M 1.51B 7.42M 6.44M 6.03M 5.52M 10.42M 707M 10.56M 70.58M 27.7M 353M 27.88M 27.27M 1.18B
Net income -1.6M -1.39M -1.3M -1.19M -2.24M -152M -2.27M -15.19M -5.96M -76.07M -6M -5.87M -253M -2.98M -2.59M -2.43M -2.22M -4.19M -284M -4.24M -28.37M -11.13M -142M -11.21M -10.96M -473M
Net Debt -4.15M -3.6M -3.37M -3.08M -5.82M -395M -5.9M -39.45M -15.48M -198M -15.58M -15.24M -657M -3.81M -3.31M -3.1M -2.84M -5.35M -363M -5.42M -36.26M -14.23M -182M -14.32M -14.01M -604M
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
06/08/26 $1.570 +1.95% 5,763
05/08/26 $1.540 0.00% 4,053
04/08/26 $1.540 +7.69% 8,710
03/08/26 $1.430 +8.33% 108,915
31/07/26 $1.320 0.00% 10,006
  1. Stock Market
  2. Stocks
  3. BGLC Stock